PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study

Patients with type 2 diabetes face an increased risk of macrovascular disease compared to those without. Significant reductions in the risk of major cardiovascular events can be achieved with appropriate drug therapy, although patients with type 2 diabetes remain at increased risk compared with non-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Erdmann, Erland, Dormandy, John, Wilcox, Robert, Massi-Benedetti, Massimo, Charbonnel, Bernard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2007
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2291341/
https://ncbi.nlm.nih.gov/pubmed/17969365
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller